Comparison with Other Growth Hormone Secretagogues Reference: Title: Comparative Effects of Sermorelin and Hexarelin on Growth Hormone Secretion in Aging Authors: Ezio Ghigo, Enzo Arvat, Luca Gianotti, et al
Tesamorelin has FDA approval for adult visceral fat reduction and Phase III trial data showing 15% reduction over 26 weeks
10.1089/humc.2018.121 97 YangQ
Our supplement recommendations are selected for quality, bioavailability, and clinical relevance as part of a comprehensive strategy that may include nutrition, metabolic health evaluation, hormone optimization, and preventive medical care
It has been found to be beneficial in treating conditions such as melasma, acne, hyperpigmentation, rosacea, and eczema